W. W. Chan

发表

Structure of human phosphatidylcholine transfer protein in complex with its ligand

M. Vetting, K. Rajashankar, Diana S. Agate, 2002, Nature Structural Biology.

Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor

W. W. Chan, A. Pang, Y. Kwong, 2006, Leukemia.

Switch Pocket Inhibitors of the ABL Tyrosine Kinase: Distinct Kinome Inhibition Profiles and in Vivo Efficacy in Mouse Models of CML and B-Lymphoblastic Leukemia Induced by BCR-ABL T315I

R. A. Etten, C. Walz, W. W. Chan, 2008 .

Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.

B. Neel, Shengqing Gu, Azin Sayad, 2016, Blood.

Title Distinct GAB 2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL 1 Permalink

B. Neel, Shengqing Gu, Azin Sayad, 2016 .

Distinct GAB 2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL 1

B. Neel, Shengqing Gu, Azin Sayad, 2016 .

Human phosphatidylcholine transfer protein: purification, crystallization and preliminary X-ray diffraction data.

D. Cohen, S. Roderick, W. W. Chan, 2002, Biochimica et biophysica acta.

Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias

W. W. Chan, Y. Kwong, C. Chim, 2008, Journal of Clinical Pathology.

Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036.

L. Stewart, R. V. van Etten, T. Haack, 2011, Cancer cell.

A Selective and Potent Oral Inhibitor of the JAK2 Tyrosine Kinase Reverses Polycythemia and Leukocytosis Induced by JAK2 V617F in a Mouse Model.

R. A. Etten, R. Chopra, D. Huszar, 2007 .

High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain.

D. Cohen, S. Roderick, W. W. Chan, 2000, Biochemistry.

DCC-2036: A Novel Switch Pocket Inhibitor of ABL Tyrosine Kinase with Therapeutic Efficacy Against BCR-ABL T315I In Vitro and in a CML Mouse Model.

C. Peng, R. A. Etten, Shaoguang Li, 2007 .